TickerFacts.

Compare

NeoGenomics Inc vs UL Solutions Inc. vs Hypha Labs, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNeoGenomics Inc
NEO		UL Solutions Inc.
ULS		Hypha Labs, Inc.
FUNI
Year ended2025-12-312025-12-312025-09-30
Revenue$727.33M$3.05Bn/a
Revenue growth (YoY)+10.1%+6.4%n/a
Gross margin43.2%49.5% (computed)n/a
Operating margin-15.9%17.1%n/a
Net margin-14.9%10.6%n/a
Net income-$108.03M$325.00M-$3.10M
EPS (Diluted)n/a$1.60-$0.02
Operating cash flow$5.23M$600.00M-$380.0K
Free cash flow-$21.78M$403.00M-$412.9K
Cash & equivalents$159.62M$295.00Mn/a
Total assets$1.36B$2.92B$409.2K
Total liabilities$523.27M$1.63B$2.51M
Shareholders' equity$836.56M$1.29B-$2.44M
Return on year-end equity-12.9%25.1%n/a
Shares outstanding128.15M201.03M147.12M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNeoGenomics IncUL Solutions Inc.Hypha Labs, Inc.
Latest$727.33M
Ended 2025-12-31		$3.05B
Ended 2025-12-31		$2.70M
Ended 2022-09-30
1 year earlier$660.57M
Ended 2024-12-31		$2.87B
Ended 2024-12-31		$2.50M
Ended 2021-09-30
2 years earlier$591.64M
Ended 2023-12-31		$2.68B
Ended 2023-12-31		$2.57M
Ended 2020-09-30
3 years earlier$509.73M
Ended 2022-12-31		$2.52B
Ended 2022-12-31		$2.55M
Ended 2019-09-30
4 years earlier$484.33M
Ended 2021-12-31		n/a$2.84M
Ended 2018-09-30